POSTER PRESENTATIONS

1. Huynh, T.C.,Gupta R., and Bhatnagar, S. Early phase insulin secretion regulated by tomosyn abundance via synaptotagmin-9. Darwin Day UAB, Birmingham, AL, February 8, 2018. 
2. Huynh, T.C., Gupta, R., and Bhatnagar, S. Synaptotagmin-9 regulates tomosyn protein abundance to affect early phase of insulin secretion. Southeastern Medical Scientist Symposium; Atlanta, GA, November 18–19, 2017. 
3. Gupta, R., Huynh, T.C., Truong, C., and Bhatnagar, S. Synaptotagmin-9 Regulates Tomosyn-2 Protein Abundance to Affect Early Phase of Insulin Secretion. American Diabetes Association Conference: 77nd Scientific Sessions, San Diego, CA, June 9-13, 2017
4. Koltes, J., Gupta, R., Bhatnagar, S. Transcriptomics, informatics and functional analyses identify the secreted protein C1ql3 as a regulator of pancreatic beta-cell function. Keystone Symposia: Obesity and Type 2 Diabetes, Keystone, CO, January 22-27, 2017.
5. Wrighton, L., Bhatnagar, S., Keller, M.P., Chapman, E., Attie, A.D. Sytmaptotagmin-11 is required for the formation of the dense core in insulin granules. Midwest Islet Conference, Chicago, May 20th-21st, 2015.
6. Bhatnagar, S., Schneider, L.R., Hebert, A., Coon, J.J., Attie, A.D.  Insulin, cAMP, and phorbol ester-activated cell signaling pathways phosphorylate tomosyn-2 to regulate insulin secretion in pancreatic beta-cells. American Diabetes Association Conference: 73nd Scientific Sessions, Chicago, IL; June 21-25, 2013.
7. Bhatnagar, S., Schneider, L.R., Hebert, A., Soni, M.S., Keller, M.P., Coon, J.J., Attie, A.D. Glucose, cAMP, and phorbol ester-activated cell signaling pathways phosphorylate tomosyn-2 to regulate insulin secretion in pancreatic beta-cells. Complex Trait Community 12th Annual Meeting, University of Wisconsin-Madison, Madison, WI; May 28-31, 2013.
8. Soni, M.S, Keller, M.P., Rabaglia, M.E., Bhatnagar, S., Shang, J., Li, J., Zhou, H., Zhou, Y.P., Kheterpal, I., Mynatt, R., Newgard, C.B., Howard, A.D., and Attie, A.D. MiRNAs 132 and 212 Result in a Down-Regulation of CACT, Leading to an Increase in Insulin Secretion Via Fatty Acyl-Carnitine Accumulation. The Midwest Islet Club Conference, University of Michigan, Ann Harbor, MI; May 22–23, 2013.
9. Soni, M.S., Keller, M.P., Rabaglia, M.E., Bhatnagar, S., Shang, J., Zhou, Y.P., Mynatt, R., and Attie, A.D. MiRNAs 132 and 212 result in a down-regulation of CACT, leading to an increase in insulin secretion via accumulation of fatty acyl-carnitine molecules. Keystone Symposia: Diabetes - New Insights into Mechanism of Disease and its Treatment (J6), Keystone, CO; January 27 - February 1, 2013.
10. Bhatnagar, S., Schneider, L.R., Hebert, A., Coon, J.J., Attie, A.D.  Insulin, cAMP, and phorbol ester-activated cell signaling pathways phosphorylate tomosyn-2 to regulate insulin secretion in pancreatic beta-cells. Keystone Symposia: Diabetes - New Insights into Mechanism of Disease and its Treatment (J6), Keystone, CO; January 27 - February 1, 2013.
11. Bhatnagar, S., Hebert, A., Oler, A.T., Rabaglia, M.E., Schneider, L.R., Stapleton, D.S., Schueler, K.L., Keller, M.P., Coon, J.J., Attie, A.D. An E3-ubiquitin ligase regulates the activity of an inhibitor of insulin secretion. American Diabetes Association Conference: 72nd Scientific Sessions Pennsylvania Convention Center, Philadelphia, PA; June 8-12, 2012.
12. Bhatnagar, S., Oler, A.T., Rabaglia, M.R., Stapleton, D.S., Keller, M., Schueler, K.L., Attie, A.D. Positional cloning of a type 2 diabetes quantitative trait locus; Tomosyn-2, a negative regulator of insulin secretion. Keystone Symposia: Pathogenesis of Diabetes: Emerging Insights into Molecular Mechanisms (J8), Santa Fe, NM; Jan 29–Feb 3, 2012.
13. Bhatnagar, S., Oler, A.T., Rabaglia, M.R., Stapleton, D.S., Keller, M., Schueler, K.L., Attie, A.D. Positional cloning of a type 2 diabetes quantitative trait locus; Tomosyn-2, a negative regulator of insulin secretion. The Metabolism of Lipids: Implication in Human Diseases, 34th Steenbock Symposium, Madison, WI; May 22–25, 2011.
14. Bhatnagar, S., Oler, A.T., Rabaglia, M.R., Stapleton, D.S., Keller, M., Schueler, K.L., Attie, A.D. Positional cloning of a type 2 diabetes quantitative trait locus; Tomosyn-2, a negative regulator of insulin secretion. The Midwest Islet Club Conference, University of Wisconsin-Madison, Madison, WI; May 25–27, 2011.
15. Bhatnagar, S., Oler, A.T., Rabaglia, M.R., Stapleton, D.S., Keller, M., Schueler, K.L., Attie, A.D. The role of tomosyn-2 in insulin secretion. The Midwest Islet Club Conference, Indiana University School of Medicine, Indianapolis, IN; May 26–27, 2010.
16. Oler, A.T., Bhatnagar, S., Rabaglia, M.R., Stapleton, D.S., Keller, M., Schueler, K.L., Fusilier, A.M., Attie, A.D. Defective insulin secretion attributed to a diabetes susceptibility locus on mouse chromosome 16. The Midwest Islet Club Conference, St Louis, MO; May 27–29, 2009.
17. Bhatnagar, S., Hillgartner, F.B. Fibroblast Growth Factor-19: A Novel Factor for Inhibiting Fatty Acid Synthesis. FASEB Summer Conferences: Molecular Mechanisms Involved in the Nutrient Control of Cellular Function, Carefree, Arizona; July 20–25, 2008.
18. Bhatnagar, S., Hillgartner, F.B. Fibroblast Growth Factor-19 Inhibits Fatty Acid Synthesis in Hepatocytes in Culture. Keystone symposia: Diabetes Mellitus, Insulin Action and Resistance (A6), Breckenridge, CO; January 22–27, 2008.
19. Bhatnagar, S., Hillgartner, F.B. Fibroblast Growth Factor-19 Inhibits Fatty Acid Synthesis in Hepatocytes in Culture. Nuclear Receptors in Liver and Digestive Diseases: A Research Workshop, Rockville, MD; November 7–8, 2007.
20. Bhatnagar, S., Hillgartner, F.B. Fibroblast Growth Factor-19 Inhibits Fatty Acid Synthesis in Hepatocytes in Culture.  E.J. Van Liere Research Convocation and Research Day, West Virginia University, WV; 2007.
21. Srivastava, A., Prakash, N.T., Bhatnagar, S., Kumar, A., Gupta, U., Sadana, J. Selenium Toxicity in Waters, Soils and Crops in Nawashahar Region of India. 8th International Symposium on Selenium in Biology and Medicine, Selenium, University of Wisconsin, Madison, WI; July 25–30, 2006.​
22. Bhatnagar, S., Hillgartner, F.B. Fibroblast Growth Factor-19 Inhibits the Actions of Insulin, Thyroid Hormone, and Liver X Receptor Agonists on Lipogenic Gene Expression in Liver. E.J. Van Liere Research Convocation and Research Day, West Virginia University, WV; 2006.